Search results for "Psychotic"

showing 10 items of 360 documents

Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

2019

This work was supported by the Carlos III Institute of Health and European Fund for Regional Development (PI08/1213, PI11/01977, PI14/01900, PI08/01026, PI11/02831, PI14/01621, PI08/1161, PI16/00359, PI16/01164, PI18/00805), the Basque Foundation for Health Innovation and Research (BIOEF), the Secretaria d´Universitats I Recerca del Departament d´Economia I Coneixement (2017 SGR 1365), and R&D activities in Biomedicine, Madrid Regional Government and Structural Funds of the European Union (S2017/BMD-3740 (AGES-CM 2-CM)).

AdultMaleFirst episode psychosisAdolescentSocial perceptionPsicosiCognitive reservesocial cognitionNeuropsychological TestsPercepció socialPsychosocial functioning03 medical and health sciencesYoung Adult0302 clinical medicineMediatorSocial cognitionfirst episode psychosisHumansPath analysis (statistics)Applied PsychologyCognitive reservePsychiatric Status Rating ScalesMediation AnalysisPsychosesCognitionSocial cognition030227 psychiatryPsychiatry and Mental healthPsychotic DisordersLinear Modelspsychosocial functioningFemaleVerbal memoryCognitive reserve first episode psychosis psychosocial functioning social cognitionPsychologyNeurocognitivePsychosocial030217 neurology & neurosurgeryClinical psychology
researchProduct

Neuropsychological, clinical and cognitive insight predictors of outcome in a first episode psychosis study.

2012

The outcome of first episode psychosis (FEP) is highly variable and difficult to predict. We studied prospectively the impact of poor insight and neuropsychological deficits on outcomes in a longitudinal cohort of 127 FEP patients. Participants were assessed on 5 domains of cognitive function and 2 domains of insight (clinical and cognitive). At 12. months, patients were assessed again for symptom severity and psychosocial function. Regression analyses revealed that cognitive insight (a measure of self-reflectiveness and self-certainty) was the best baseline predictor of overall psychopathology at 12. months whereas executive function performance at admission to the study indicated later se…

AdultMaleFirst episode psychosisPsychosismedicine.medical_specialtyNeuropsychological TestsYoung AdultNeuropsychologyPredictive Value of TestsOutcome Assessment Health CaremedicineHumansYoung adultPsychiatrySettore MED/25 - PsichiatriaBiological PsychiatryPsychiatric Status Rating ScalesPsychopathologyNeuropsychologyCognitionRegression analysismedicine.diseasePsychiatry and Mental healthPsychotic DisordersPredictive value of testsRegression AnalysisFemaleInsightPsychologyCognition DisordersNeurocognitivePsychopathologyClinical psychologyFollow-Up StudiesSchizophrenia research
researchProduct

No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder

2015

AbstractStress is an important risk factor in the etiology of psychotic disorder. Preclinical work has shown that stress primarily increases dopamine (DA) transmission in the frontal cortex. Given that DA-mediated hypofrontality is hypothesized to be a cardinal feature of psychotic disorder, stress-related extrastriatal DA release may be altered in psychotic disorder. Here we quantified for the first time stress-induced extrastriatal DA release and the spatial extent of extrastriatal DA release in individuals with non-affective psychotic disorder (NAPD). Twelve healthy volunteers (HV) and 12 matched drug-free NAPD patients underwent a single infusion [18F]fallypride positron emission tomogr…

AdultMaleFluorine RadioisotopesDopaminePrefrontal CortexHypofrontalityStressSynaptic TransmissionTemporal lobeCellular and Molecular Neuroscienceddc:150DopamineRadioligandmedicineHumansPrefrontal cortexBiological PsychiatryTemporal cortexPositive and Negative Syndrome ScaleBrainMiddle AgedTemporal Lobe3. Good healthNeostriatumPsychiatry and Mental healthFallypridePsychotic DisordersCase-Control StudiesPositron-Emission TomographyBenzamidesPsychologicalFemaleOriginal ArticlePsychologyNeuroscienceStress Psychologicalmedicine.drug
researchProduct

Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem study

2016

Schizophrenia is a severe neuropsychiatric disorder with impairments in social cognition. Several brain regions have been implicated in social cognition, including the nucleus caudatus, prefrontal and temporal cortex, and cerebellum. Oxytocin is a critical modulator of social cognition and the formation and maintenance of social relationships and was shown to improve symptoms and social cognition in schizophrenia patients. However, it is unknown whether the oxytocin receptor is altered in the brain. Therefore, we used qRT-PCR and Ornithine Vasotocin Analog ([125I]OVTA)-based receptor autoradiography to investigate oxytocin receptor expression at both the mRNA and protein level in the left p…

AdultMaleGene ExpressionVasotocinReal-Time Polymerase Chain ReactionLeft nucleusRats Sprague-Dawley03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineHaloperidolAnimalsHumansRNA MessengerClozapineBiological PsychiatryClozapineAgedAged 80 and overTemporal cortexBinding SitesBrainMiddle Agedmedicine.diseaseOxytocin receptor030227 psychiatryPsychiatry and Mental healthchemistryOxytocinReceptors OxytocinSchizophreniaSchizophreniaAutoradiographyHaloperidolFemalePsychologyNeurosciencehormones hormone substitutes and hormone antagonists030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drugSchizophrenia Research
researchProduct

Psychotic-like experiences in the general population of Buenos Aires city

2011

AdultMaleGerontologyeducation.field_of_studyPopulationArgentinaMEDLINECommunity health planningCommunity Health PlanningYoung AdultPsychiatry and Mental healthPsychotic DisordersLinear ModelsHumansFemaleYoung adulteducationPsychologyBiological PsychiatrySchizophrenia Research
researchProduct

Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up

2018

In recent years, the effects of cannabis use on cognitive functions in patients with psychosis have been widely studied. Recently, special emphasis has been placed on the impact of age at the onset of consumption on cognition in these patients.349 patients with a first episode of non-affective psychosis were studied. Patients were classified as cannabis users and non-users. Users were divided, according to their age when they began using cannabis, into: early-onset (age  16) and late-onset (age ≥ 16) users. Differences between groups at baseline were studied based on sociodemographic, clinical, and cognitive variables. The groups were longitudinally (3-year) compared on cognitive variables.…

AdultMaleMarijuana AbusePsychosismedicine.medical_specialty030508 substance abuseYoung Adult03 medical and health sciencesCognition0302 clinical medicineMemoryHumansMedicineLongitudinal StudiesAge of OnsetPsychiatryBiological PsychiatryEffects of cannabisFirst episodebiologybusiness.industryCognitionbiology.organism_classificationmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesPsychotic DisordersDisease ProgressionSpeech PerceptionFemaleMarijuana UseCannabisVerbal memoryAge of onset0305 other medical sciencebusinessNeurocognitive030217 neurology & neurosurgeryFollow-Up StudiesSchizophrenia Research
researchProduct

Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls

2013

Background—Despite increasing evidence suggesting that childhood maltreatment is significantly associated with psychosis, the specific role of bullying in the onset of psychotic disorders is still unclear. This study aimed to examine whether bullying was more prevalent amongst individuals presenting to services for the first time with a psychotic disorder than in unaffected community controls. Methods—Data on exposure to bullying, psychotic symptoms, cannabis use and history of conduct disorder were collected cross-sectionally from 222 first-presentation psychosis cases and 215 geographically-matched controls. Bullying victimisation was assessed retrospectively as part of the Brief Life Eve…

AdultMaleMarijuana AbusePsychosismedicine.medical_specialtyAdolescentPoison controlPsychosiVictimisationArticleOccupational safety and healthYoung AdultRisk FactorsSurveys and QuestionnairesInjury preventionPrevalencemedicineHumansYoung adultFirst episodePsychiatryCrime VictimsBiological PsychiatryRetrospective StudiesPsychiatric Status Rating ScalesFirst episodeBullyingmedicine.diseasePsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaVictimisationFemalePsychologyBullying; First episode; Psychosis; Schizophrenia; VictimisationClinical psychologySchizophrenia Research
researchProduct

Schizophrenic patients who smoke have a faster finger tapping rate than non-smokers

2002

The increased rate of smoking in schizophrenia patients remains unexplained and may reflect attempts at self-treatment. The effect sought from smoking may be related to nicotine's stimulating action. We tested this hypothesis by examining the relationship between smoking status and finger tapping rate, a measure of central processing, in schizophrenia patients treated with atypical antipsychotics. Smokers showed significantly faster finger tapping rates than non-smokers. This was not related to clinical state, illness chronicity, medication side-effects, antipsychotic dose or plasma concentrations. Nicotine can improve central processing in medicated schizophrenia patients and this may cons…

AdultMaleNicotinemedicine.medical_specialtyPatientsMovementmedicine.medical_treatmentClinical stateFingersNicotineInternal medicinemedicineHumansPharmacology (medical)Nicotinic AgonistsAntipsychoticPsychiatryBiological PsychiatryPharmacologySmokeAnalysis of VarianceSmokingMiddle Agedmedicine.diseasePsychiatry and Mental healthNeurologySchizophreniaFinger tappingPlasma concentrationSchizophreniaSmoking statusNeurology (clinical)PsychologyPsychomotor Performancemedicine.drugEuropean Neuropsychopharmacology
researchProduct

High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia.

2003

The 'atypicality' of the antipsychotic drug, amisulpride, has been attributed to preferential extrastriatal binding. Previous investigations of striatal D2 receptor occupancy by amisulpride revealed conflicting results. The aim of this PET study was to measure the striatal occupancy by amisulpride and to correlate it with the corresponding drug plasma concentrations. Nine amisulpride-treated patients and 12 healthy volunteers serving as controls were studied with PET and [18F]desmethoxyfallypride. Occupancy values and plasma concentrations were nonlinearly fitted to an E max model. Results showed 43-85% (putamen) and 67-90% (caudate) D2-like receptor occupancy. Plasma amisulpride concentrat…

AdultMaleOccupancyPharmacologyDopamine receptor D2Image Interpretation Computer-AssistedSalicylamidesmedicineHumansPharmacology (medical)AmisulprideReceptorPharmacologyCerebral CortexChemistryReceptors Dopamine D2PutamenDesmethoxyfallypridePutamenMiddle Agedmedicine.diseaseNeostriatumPsychiatry and Mental healthSchizophreniaDopamine receptorArea Under CurvePositron-Emission TomographySchizophreniaFemaleAmisulprideCaudate NucleusRadiopharmaceuticalsSulpirideAlgorithmsmedicine.drugAntipsychotic AgentsThe international journal of neuropsychopharmacology
researchProduct

Subchronic Effects of Olanzapine on Sleep EEG in Schizophrenic Patients with Predominantly Negative Symptoms

2004

Background It is well known that sleep disturbance is an integral symptom of schizophrenia. In recent studies, a deficit of delta sleep has been observed in schizophrenic patients. Antipsychotic drugs with serotonin (5-HT2) receptor-antagonistic properties are considered to have delta sleep promoting effects. We have investigated the effects of subchronic olanzapine treatment on sleep EEG in schizophrenic patients. Methods The effects of administration of olanzapine (15 to 20 mg) on sleep were studied for four weeks in 10 male, drug-free patients suffering from schizophrenia with predominantly negative symptoms. Conventional sleep EEG parameters were investigated at baseline and after treat…

AdultMaleOlanzapineAdolescentPolysomnographymedicine.medical_treatmentPolysomnographySeverity of Illness IndexDrug Administration ScheduleBenzodiazepinesSurveys and QuestionnairesmedicineHumansPharmacology (medical)AntipsychoticSleep disorderSleep Stagesmedicine.diagnostic_testElectroencephalographyGeneral MedicineMiddle Agedmedicine.diseaseSleep in non-human animalsDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthDelta RhythmOlanzapineSchizophreniaAnesthesiaDelta RhythmSchizophreniaSchizophrenic PsychologySleep StagesPsychologyAntipsychotic Agentsmedicine.drugPharmacopsychiatry
researchProduct